What Legal Issues Arise in an Advertising Case?

Advertising cases typically rest on one or more of these legal foundations: false advertising under the Lanham Act (federal trademark law), state consumer protection statutes, common-law fraud or misrepresentation, and regulatory enforcement by agencies such as the Federal Trade Commission or state attorneys general. Each theory carries distinct burdens of proof, remedies, and defenses.

Under federal law, the Lanham Act prohibits any person from using false or misleading representations in commerce that are likely to cause confusion or deceive consumers about the origin, sponsorship, or approval of goods or services. State consumer protection laws often mirror this framework but may impose different standards for materiality, reliance, or injury. Common-law fraud claims require proof of a material misrepresentation, scienter (knowledge of falsity or reckless disregard), reasonable reliance, and resulting damages. The critical distinction for corporate defendants is that regulatory agencies do not require proof of intent or consumer reliance, whereas private litigation typically does.

Substantiation is a cornerstone concept in advertising law. The FTC's Guides require that advertisers possess a reasonable basis for any objective claim before dissemination. A reasonable basis typically means competent and reliable scientific evidence for health or efficacy claims. Failing to retain or produce substantiation when challenged creates significant exposure, as courts and regulators may infer falsity from the absence of support. For corporate defendants, the timing and completeness of internal documentation become critical to both liability and damages calculations.

The FTC and state attorneys general pursue advertising enforcement through administrative proceedings and civil litigation. Understanding the procedural posture of regulatory action helps corporate defendants assess settlement leverage and compliance obligations early.

When the FTC initiates an investigation, it typically issues Civil Investigative Demands (CIDs) requesting documents, interrogatory responses, and depositions. Failure to comply with a CID can result in contempt sanctions and adverse inferences. The FTC may then issue a complaint alleging unfair or deceptive practices and seek a consent order or litigate before an administrative law judge. State attorneys general operate under parallel state consumer protection statutes and may bring standalone actions or coordinate with federal enforcement. In New York, the Attorney General's office frequently pursues advertising claims under General Business Law Section 349, which prohibits deceptive practices in trade or commerce; a procedural defect in notice or service of a cease-and-desist demand can affect the enforceability of subsequent penalties, though courts generally favor reaching the merits rather than dismissing on technical grounds.

Corporate defendants should document all communications with regulators, preserve responsive materials, and evaluate early settlement or compliance offers carefully. Consent orders often include injunctive provisions, corrective advertising obligations, and ongoing monitoring or reporting requirements. The cost of compliance and reputational impact of a public settlement merit early strategic analysis alongside litigation risk.

A robust substantiation record is the primary defense against advertising liability. Courts and regulators assess whether an advertiser possessed a reasonable basis for claims at the time of dissemination, not retroactively.

Types of competent evidence include clinical studies, expert opinions, consumer surveys, internal testing data, and published research. For health claims or performance assertions, the FTC typically requires randomized, controlled trials or equivalent scientific rigor. For subjective or opinion-based claims (e.g., "best," "finest," "superior"), substantiation standards are lower, but the claim must still not imply an objective fact that is false or unsupported. A corporate defendant's internal files revealing that a claim was made without testing, or that testing contradicted the claim, can be devastating at trial or in regulatory proceedings. Conversely, a well-organized substantiation file demonstrates reasonable care and may support a good-faith defense or reduce damages exposure.

Comparative advertising claims (comparing one product to a competitor's) trigger heightened scrutiny. The advertiser must substantiate not only its own claims but also the basis for comparative assertions. Failure to do so can support a Lanham Act claim by the competitor and invite regulatory challenge. Practitioners often advise clients to maintain a substantiation protocol before launch, document the basis for all material claims, and conduct periodic compliance audits of active campaigns.

Courts and regulators frequently grant injunctive relief in advertising cases, ordering the defendant to cease the challenged conduct and, in some cases, to fund corrective advertising that discloses the falsity or corrects consumer misimpressions.

An injunction is typically available upon a showing of likelihood of success on the merits, irreparable harm, and balance of equities favoring the plaintiff. In advertising cases, courts often find irreparable harm because false advertising can damage reputation and market position in ways that money damages cannot fully remedy. Corrective advertising orders require the defendant to spend a percentage of advertising budgets (often 25 percent or more) on corrective messages for a specified period. The purpose is to counteract consumer confusion or false beliefs created by prior false advertising. For a corporate defendant, the financial burden of corrective advertising can exceed the damages award itself, making settlement or early intervention highly valuable.

Scope of injunction language matters significantly. A narrowly tailored injunction that prohibits only the specific false claim may be easier to comply with and appeal than a broad order affecting all marketing. Defendants should scrutinize proposed injunctive language for ambiguity or overreach and propose specific, measurable compliance metrics. In litigation, the difference between a 12-month and 36-month corrective advertising obligation can shift settlement economics substantially.

Early case assessment, document preservation, and regulatory coordination are essential. A corporate defendant facing an advertising claim should immediately halt the challenged conduct, preserve all internal communications and substantiation files, and evaluate whether regulatory disclosure is required (e.g., notification to securities regulators or disclosure in financial filings if material).

Litigation timing and venue can affect outcome. Federal court may offer procedural predictability and appellate precedent, whereas state court may involve juries less familiar with advertising law nuances. Regulatory proceedings typically move faster than civil litigation and may offer settlement pathways unavailable in court. Class action exposure warrants early assessment of numerosity, commonality, and damages models; a weak class certification posture may support early settlement at a discount to individual damages exposure.

Documentation and communications discipline going forward are critical. Any admission of falsity, internal debate about claim accuracy, or email suggesting knowledge of a problem can be used against the defendant. Counsel should advise on privilege and work-product protections for internal investigations and communications with in-house legal teams. For advertising and marketing law compliance, implementing a pre-launch review process, maintaining substantiation files, and conducting periodic audits reduce future exposure. Practitioners working on administrative cases involving regulatory enforcement should assess settlement authority early, as delay often increases penalties and reputational damage.